Skip to main content

Table 3 Five-year adjusted conditional PCSM for patients with M1a, M1b or M1c disease

From: Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis

5-year PCSM

M1a

M1b

M1c

at diagnosis

55.0 % (ref)

59.7 % (ref)

62.6 % (ref)

after 5 years

42.4 % (p < 0.005)

49.1 % (p < 0.001)

46.5 % (p < 0.005)

after 10 years

34.4 % (p < 0.005)

36.0 % (p = 0.055)

39.6 % (p < 0.005)

after 15 years

17.0 % (p < 0.005)

29.7 % (p < 0.001)

48.7 % (p = 0.221)